Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Hims & Hers Health has proposed a convertible senior notes offering, a healthcare services other business in the United States. Hims & Hers Health operates a digital health platform that supports telehealth services, subscriptions, and AI-driven product development for consumers. The company plans to use the financing to fund international expansion and accelerate investment in its AI-enabled platform capabilities. This healthcare M&A financing supports other acquisition initiatives and broader healthcare services other acquisition strategy, with deal size undisclosed and terms expected to be finalized through the proposed notes process.
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026